The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes

Thrombosis Research

Volumn 126, Issue 5, 2010, Pages 418-425

  Basavaraj, Manjunath Goolyam ^a   Gruber, Franz X ^a   Sovershaev, Mikhail ^b   Appelbom, Hege I ^a   Østerud, Bjarne ^a   Petersen, Lars C ^c   Hansen, John Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Monocytes; Thrombin; Tissue Factor; Tissue factor pathway inhibitor

Indexed keywords

IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; MESSENGER RNA; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTIGEN PRESENTATION; ARTICLE; BLOOD CLOTTING; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; THROMBOGENICITY;

ADULT; FLOW CYTOMETRY; HUMANS; LIPOPROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; THROMBOPLASTIN; THROMBOSIS;

EID: 78149281495     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.014     Document Type: Article

References (33)

1. B. Osterud, M.S. Bajaj, and S.P. Bajaj Sites of tissue factor pathway inhibitor (TFPI) and tissuefactor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH Thromb Haemost 73 1995 873 875
2. B. Osterud, and S.I. Rapaport Activation of factor IX by the reaction product of tissue factor andfactor VII: additional pathway for initiating blood coagulation Proc Natl Acad Sci U S A 74 1977 5260 5264
3. S.I. Rapaport, and L.V. Rao Initiation and regulation of tissue factor- dependent blood coagulation Arterioscler Thromb 12 1992 1111 1121
4. E.W. Leatham, P.M. Bath, J.A. Tooze, and A.J. Camm Increased monocyte tissue factor expression in coronary disease Br Heart J 73 1995 10 13
5. I. Ott, M. Andrassy, D. Zieglgänsberger, S. Geith, A. Schömig, and F.J. Neumann Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 Blood 97 2001 3721 3726
6. B. Osterud, and T. Flaegstad Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis Thromb Haemost 49 1983 5 7
7. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (2) N Engl J Med 326 1992 310 318
8. J.N. Wilcox, K.M. Smith, S.M. Schwartz, and D. Gordon Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci U S A 86 1989 2839 2843
9. V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, and A. Fernández-Ortiz Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
10. G.J. Broze Jr., L.A. Warren, W.F. Novotny, D.A. Higuchi, J.J. Girard, and J.P. Miletich The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action Blood 71 1988 335 343
11. B.J. Warn-Cramer, L.V. Rao, S.L. Maki, and S.I. Rapaport Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition Thromb Haemost 60 1988 453 456
12. B.J. Warn-Cramer, F.E. Almus, and S.I. Rapaport Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells Thromb Haemost 61 1989 101 105
13. M.S. Bajaj, M.N. Kuppuswamy, H. Saito, S.G. Spitzer, and S.P. Bajaj Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis Proc Natl Acad Sci U S A 87 1990 8869 8873
14. J. Zhang, O. Piro, L. Lu, and G.J. Broze Jr. Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor Circulation 108 2003 623 627
15. I. Ott, Y. Miyagi, K. Miyazaki, M.J. Heeb, B.M. Mueller, and L.V. Rao Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor Arterioscler Thromb Vasc Biol 20 2000 874 882
16. O. Piro, and G.J. Broze Jr. Comparison of cell-surface TFPIalpha and beta J Thromb Haemost 3 2005 2677 2683
17. S.A. Maroney, P.E. Ellery, and A.E. Mast Alternatively spliced isoforms of tissue factor pathway inhibitor Thromb Res 125 2010 S52 S56
18. M.P. McGee, S. Foster, and X. Wang Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localised control of blood coagulation J Exp Med 179 1994 1847 1854
19. M.S. Bajaj, M. Ghosh, and S.P. Bajaj Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications J Thromb Haemost 5 2007 1493 1499
20. E. Erhardtsen, M. Ezban, M.T. Madsen, V. Diness, S. Glazer, and U. Hedner Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A Blood Coagul Fibrinolysis 6 1995 388 394
21. C.K. Kasper, L. Aledort, D. Aronson, R. Counts, J.R. Edson, and J. van Eys Proceedings: A more uniform measurement of factor VIII inhibitors Thromb Diath Haemorrh 34 1975 612
22. J.B. Hansen, D.S. Halvorsen, B.C. Haldorsen, R. Olsen, H. Sjursen, and P. Kierulf Retention of phagocytic functions in cryopreserved human monocytes J Leukoc Biol 57 1995 235 241
23. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, and M. Kubista The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin Chem 55 2009 611 622
24. E. Beillard, N. Pallisgaard, V.H. van der Velden, W. Bi, R. Dee, and E. van der Schoot Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program Leukemia 17 2003 2474 2486
25. B. Osterud Platelet activating factor enhancement of lipopolysaccharide- induced tissue factor activity in monocytes: requirement of platelets and granulocytes J Leukoc Biol 51 1992 462 465
26. H.C. Hemker, and P. Giesen Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
27. E.M. Egorina, M.A. Sovershaev, J.O. Olsen, and B. Østerud Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer Blood 111 2008 1208 1216
28. T.C. Wun, K.K. Kretzmer, T.J. Girard, J.P. Miletich, and G.J. Broze Jr Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tndem Kunitz-type inhibitory domains J Biol Chem 263 1988 6001 6004
29. J.Y. Chang, D.M. Monroe, J.A. Oliver, and H.R. Roberts TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene Thromb Haemost 81 1999 45 49
30. C.P. van der Logt, R.J. Dirven, P.H. Reitsma, and R.M. Bertina Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester Blood Coagul Fibrinolysis 5 1994 211 220
31. P. Nguyên, M. Broussas, P. Cornillet-Lefèbvre, and G. Potron Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation.Response of nonadherent cells to lipopolysaccharide Transfusion 39 1999 975 982
32. P. Kierulf, and A.B. Andersen Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed Pathobiology 59 1991 197 199
33. L.T. Osnes, A.B. Westvik, and P. Kierulf Procoagulant and profibrinolytic activities of cyopreserved human monocytes Thromb Res 76 1994 373 383